Case
Carbon footprint reduced for Wellspect products.
Knightec Group’s life science experts provided support to the medtech company Wellspect when it expanded its catheter production. The result was both a reduced carbon footprint and maintained quality for the best possible user experience.
ClientWellspect
IndustryLife Science
ServicesSustainable BusinessCompliance & SafetyProduction & IndustrialisationProject & Change Management
Originally delivered by Semcon, now part of Knightec Group.
Background
In 1983, global medtech company Wellspect launched the LoFric® urine catheter. The catheter helps sufferers of urinary tract problems to live active lives thanks to its unique, very slippery coating, Urotonic™ Surface Technology, which makes it gentle and easy to use. Expanding the production made it necessary to replace the process equipment, and Wellspect decided to take an even greater step forward than demanded by the authorities. Semcon provided support with experienced consultants in several areas, in particular with excellence in validation.
Challenge
In 1983, global medtech company Wellspect launched the LoFric® urine catheter. The catheter helps sufferers of urinary tract problems to live active lives thanks to its unique, very slippery coating, Urotonic™ Surface Technology, which makes it gentle and easy to use. Expanding the production made it necessary to replace the process equipment, and Wellspect decided to take an even greater step forward than demanded by the authorities. Knightec Group provided support with experienced consultants in several areas, in particular with excellence in validation.
Driving sustainable innovation through long-term collaboration.
Knightec Group and Wellspect have built a strong partnership over more than a decade, enabling efficient collaboration in complex and resource-intensive projects such as the new coating process for LoFric catheters. Operating within the highly regulated Life Science industry, the project required extensive validation and quality assurance. The goal was to significantly reduce the carbon footprint while maintaining the catheter’s unique performance and quality—an uncompromising requirement aligned with both companies’ shared commitment to improving everyday life for users.
Throughout the project, Knightec Group provided broad and flexible support, contributing expertise in validation, project management, production, and R&D. By scaling resources according to Wellspect’s evolving needs, Semcon helped maintain momentum across multiple parallel initiatives, ensuring both progress in the coating project and continuity in ongoing operations.
Delivered Value
The project enabled Wellspect to significantly reduce the carbon footprint of its catheter production—cutting emissions by up to half—while maintaining the same high product quality and user experience. By combining sustainability improvements with robust validation and industrialisation expertise, the solution ensures regulatory compliance, efficient production, and continued innovation, ultimately delivering both environmental impact and long-term value for users and the healthcare system.
